Skip to main content
. 2019 Oct 14;16(20):3890. doi: 10.3390/ijerph16203890

Table 2.

Univariate analysis of comorbidities with in-hospital mortality and length of stay.

Comorbidities Frequency (%) In-Hospital Mortality LOS (day)
N (%) p Value Mean ± SD p Value
Rheumatic
heart disease
no 2655 (99.70) 226 (8.51) 0.0002 7.32 ± 2.56 0.8367
yes 8 (0.30) 2 (25.00) 6.88 ± 3.18
Heart Failure
no 2615 (98.20) 222 (8.49) 0.3251 7.31 ± 2.56 0.9827
yes 48 (1.80) 6 (12.50) 7.35 ± 2.37
Cardiogenic Shock
no 2392 (89.82) 204 (8.53) 0.8550 7.27 ± 2.57 0.0137
yes 271 (10.18) 24 (8.86) 7.68 ± 2.43
Hypertension
no 1998 (75.03) 167 (8.36) 0.5155 7.30 ± 2.57 0.8212
yes 665 (24.97) 61 (9.17) 7.35 ± 2.53
Cerebrovascular disease
no 2253 (84.60) 205 (9.10) 0.0022 7.29 ± 2.60 0.5060
yes 410 (15.40) 23 (5.61) 7.43 ± 2.32
Gastrointestinal disease
no 2620 (98.39) 226 (8.63) 0.3555 7.32 ± 2.56 0.5060
yes 43 (1.61) 2 (4.65) 7.05 ± 2.54
Type-I DM
no 2307 (86.63) 200 (8.67) 0.6138 7.29 ± 2.60 0.5357
yes 356 (13.37) 28 (7.87) 7.48 ± 2.26
Type-II DM
no 2322 (87.19) 197 (8.48) 0.7084 7.33 ± 2.56 0.4519
yes 341 (12.81) 31 (9.09) 7.23 ± 2.52
Renal failure
no 2451 (92.04) 206 (8.40) 0.3247 7.34 ± 2.54 0.3972
yes 212 (7.96) 22 (10.38) 7.00 ± 2.71
Dysrhythmia
no 2485 (93.32) 216 (8.69) 0.3689 7.29 ± 2.57 0.1766
yes 178 (6.68) 12 (6.74) 7.66 ± 2.69
Peripheral Vascular Disease
no 2389 (89.71) 201 (8.41) 0.4196 7.30 ± 2.58 0.9493
yes 274 (10.29) 27 (9.85) 7.41 ± 2.32
COPD
no 2525 (94.82) 215 (8.51) 0.7113 7.30 ± 2.56 0.1561
yes 138 (5.18) 13 (9.42) 7.61 ± 2.43
Liver disease
no 2615 (98.20) 224 (8.57) 0.9545 7.31 ± 2.56 0.4408
yes 48 (1.80) 4 (8.33) 7.60 ± 2.44
Hypercholesterolemia
no 1614 (60.61) 140 (8.67) 0.7972 7.22 ± 2.59 0.0499
yes 1049 88 (8.39) 7.46 ± 2.50
Thyroid Disorder
no 1950 175 (8.97) 0.2082 7.19 ± 2.62 <0.0001
yes 713 53 (7.43) 7.65 ± 2.34

Abbreviation: LOS, length of stay; SD, standard deviation; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus.